Category: Women’s health · Preventive medicine · Menopause
Perimenopause at 40–55: Using a Symptom Questionnaire, When FSH/LH Tests Actually Help, Mammogram Schedules in Thailand vs Europe, and Protecting Bone and Heart
AI Overview / Quick Answer (BLUF)
Perimenopause happens as ovarian function declines and hormones swing irregularly. Women aged 45 and over with clear symptoms do not need an FSH test to confirm it.
What matters is logging symptoms, getting mammograms by age and risk, and checking blood pressure, lipids, glucose and fracture risk.
Menopause (MedlinePlus, NIH) ·
NICE guideline NG23 ·
Red flags ·
What happens in the body ·
Symptom questionnaires ·
FSH/LH and mammograms ·
Prevention ·
FAQ
Note: this article does not diagnose anyone, and the reader story below has been rewritten without identifying details.
A common question in women’s health groups: at this age, what should I get checked?
Many members in their late 40s and early 50s describe tiring easily, waking at night, and irregular periods.
One member took her symptom questionnaire results to a gynecologist and came away with clearer advice on which tests to do next.
The follow-up questions are always the same: do I need a hormone blood test, when should mammograms start, and what does my coverage include?
This article summarizes international criteria and PubMed research on which tests are truly useful at this age, which are usually unnecessary,
and why a questionnaire is not a diagnosis but a tool to rank symptoms before you talk to your doctor.
When to see a doctor without waiting (Red Flags)
- Any vaginal bleeding after 12 months without a period — even a small amount needs a gynecologist
- Periods so heavy you change pads every 1–2 hours, large clots, or dizziness and palpitations from blood loss
- Bleeding between periods or after sex
- A lump in the breast or armpit, skin dimpling, a newly inverted nipple, or bloody nipple discharge — do not wait for your next mammogram
- Missed periods or menopause symptoms before age 40 — possible premature ovarian insufficiency
- A fracture from a minor fall, or clear loss of height
- Low mood or loss of interest in almost everything for more than 2 weeks, or thoughts of self-harm — contact a mental health crisis line (Thailand: 1323)
- Chest pain or pressure with sweating, breathlessness, or pain spreading to the arm or jaw — do not assume it is just hormonal palpitations
For emergencies such as severe chest pain or bleeding heavy enough to cause fainting, call emergency services (Thailand: 1669).
1. Women’s physiology: what happens during perimenopause
STRAW+10: the menstrual cycle comes first
The STRAW+10 reproductive staging criteria (Harlow 2012)
split the transition into two stages. The early stage is a persistent difference of 7 days or more in the length of consecutive cycles.
The late stage begins with gaps of 60 days or more without a period, usually lasts 1–3 years, and a random FSH level is often above 25 IU/L.
Menopause is confirmed after 12 consecutive months without a period. The criteria apply regardless of age, ethnicity or body size.
Hormones do not fall in a straight line
Early on, fewer remaining eggs make the brain release more FSH to push the ovaries, so estrogen swings sharply and some months run higher than before.
Progesterone falls first because ovulation becomes less frequent, which explains heavy or spaced-out periods, breast tenderness and mood swings.
A single FSH result cannot confirm menopause, because it may be high one day and normal again the next month.
This table summarizes symptom groups, mechanisms, long-term effects and what you can do. On mobile it shows as cards.
| Symptom group | Hormone mechanism | Long-term effects to monitor | What to do and check |
|---|---|---|---|
| Cycle changes, heavy or spaced-out periods | Less ovulation, lower progesterone, sharp estrogen swings | Anemia from blood loss, abnormal thickening of the uterine lining | Log dates and flow, check blood count if heavy, see a doctor for red flags |
| Hot flashes, night sweats | Low estrogen makes the brain’s temperature center more sensitive | Lost sleep and quality of life, may last years | CBT, hormone or nonhormone medicine as prescribed |
| Insomnia, waking at night | Hot flashes wake you, stress, falling progesterone | Fatigue, poorer focus, higher depression risk | CBT for insomnia; ask about sleep apnea if you snore loudly |
| Mood swings, depression | Hormone swings affect neurotransmitters, plus midlife stressors | Depression, especially with a past history | Mood screening; see a psychiatrist or psychologist if it lasts over 2 weeks |
| Vaginal dryness, burning, urinary frequency | Vaginal and urethral lining thins when estrogen is low | Usually worsens without treatment, recurrent urinary infections | Lubricants, low-dose vaginal estrogen as prescribed |
| Joint aches, bone thinning | Low estrogen lets bone breakdown outpace bone formation | Osteoporosis, fragility fractures | Weight-bearing exercise, fracture-risk assessment, bone density per criteria |
| Weight gain, belly fat | Fat shifts to the abdomen, blood lipids change | Higher cardiovascular risk | Measure waist; check blood pressure, lipids and glucose |
2. Hormone symptom questionnaires: what they do and what they cannot do
Questionnaires with research behind them
The Menopause Rating Scale (Heinemann 2004)
has 11 items scored 0–4, grouped into somatic, psychological and urogenital symptoms.
Tested in 9 countries on 4 continents, it showed good reliability for measuring severity and tracking symptoms before and after treatment.
Questionnaires like this show which symptom group is heaviest and make conversations with your doctor more focused.
What a questionnaire cannot do
The real benefit comes when the result leads to evidence-based screening such as mammograms, control of blood pressure, lipids and glucose, and seeing a doctor for red flags.
Log one cycle of symptoms before your visit
How severe are your menopause symptoms, and when should you not wait?
Analyze your severity level and get personalized guidance from our Advisory team —
this score shows how closely your symptoms fit the menopausal transition, how urgently they need care, and which signs you should not ignore. It is not a diagnosis.
3. Testing guide: FSH, LH and mammograms (coverage and age ranges)
FSH and LH: when testing is actually useful
The UK’s NICE NG23 guideline states that
women aged 45 and over with clear symptoms do not need an FSH test; diagnosis rests on symptoms and cycle pattern.
A doctor may check FSH at ages 40–45 with symptoms and cycle changes, or under 40 when premature ovarian insufficiency is suspected.
FSH cannot be interpreted while using combined hormonal contraception or high-dose progestogens.
LH is not used to confirm perimenopause because it is not part of the STRAW+10 criteria; doctors may order it when another condition is suspected.
For symptoms that mimic menopause, such as palpitations, fatigue or weight change, a doctor may check thyroid function and blood count to rule out other causes.
Mammograms: how Thailand, the US and Europe differ
The US Preventive Services Task Force (USPSTF 2024)
recommends a mammogram every 2 years for average-risk women aged 40–74.
The European guidelines (Schünemann 2020)
give a strong recommendation at 50–69 every 2 years, conditional recommendations at 45–49 every 2–3 years and at 70–74 every 3 years,
and recommend against organized screening at 40–44.
In Thailand, the National Health Security Office (NHSO)
added mammogram plus ultrasound for women of every coverage scheme aged 40 and over with a first-degree relative with breast cancer, once every 2 years, from fiscal year 2025.
Average-risk women do not yet have a national mammogram program; they rely on breast self-awareness and clinical breast exams,
and should discuss screening intervals with a doctor based on their own risk and coverage (NHSO hotline 1330).
concluded that women aged 50–69 invited to mammography had on average a 23% lower risk of dying from breast cancer, and those who attended had about a 40% lower risk.
The trade-offs are false positives and detection of lesions that may never progress, so decide together with your doctor.
Other checks that matter just as much
The American Heart Association (El Khoudary 2020)
describes the menopausal transition as a time when blood lipids, body composition and vascular health shift in an unfavorable direction,
making it a key window to check blood pressure, lipids and glucose.
For bone density, the USPSTF 2025
recommends screening women 65 and over and postmenopausal women under 65 assessed as having increased fracture risk.
This table compares each test by age range and coverage. On mobile it shows as cards.
| Test | Ages 40–49 | Ages 50–55 | Thailand vs international | Benefits and limits |
|---|---|---|---|---|
| FSH | May be checked at 40–45 with symptoms; not needed at 45+ with clear symptoms | Usually not needed | Not a covered screening test; done when a doctor sees a reason | Swings widely; uninterpretable on hormonal contraception |
| LH and AMH | Not used to confirm perimenopause | Not used | Not part of STRAW+10 diagnostic criteria | Checked for other suspected conditions or fertility planning |
| Mammogram | USPSTF every 2 years; Europe conditional at 45–49 | Recommended by all guidelines, every 2 years | NHSO covers ages 40+ with a first-degree relative with breast cancer, every 2 years | Lowers deaths but has false positives; dense breasts may need extra imaging |
| Clinical breast exam and breast self-awareness | Everyone | Everyone | Thailand’s main approach for average-risk women | Prompts early visits for lumps but does not replace mammography |
| Bone density | Only with high risk, such as long-term steroid use | Postmenopausal women assessed as at higher fracture risk | USPSTF screens everyone 65 and over | Guides decisions on fracture-prevention medicine |
| Blood pressure, lipids, glucose | Check on schedule | Check on schedule | Included in age-based health promotion benefits; ask 1330 | AHA highlights the transition as the time to start heart prevention |
| Cervical cancer | On schedule | On schedule | HPV DNA testing covered at intervals set by your health unit | No need for yearly tests if results are normal; follow your doctor’s interval |
4. Habits that help with hormone change, protect bone and support mental health
Bone: the window of fastest loss
The SWAN study (Greendale 2012)
found bone loss begins about 1 year before the final menstrual period and is fastest until 2 years after it.
The spine lost 10.6% over 10 years, 7.38% of it in this window; the hip lost 9.1%, 5.8% of it in the same window.
What helps: weight-bearing and strength exercise, enough calcium from food, adequate vitamin D, no smoking and limited alcohol.
Heart and blood vessels
After menopause, women’s cardiovascular risk rises clearly (El Khoudary 2020).
Controlling waist size, regular aerobic exercise, less salt, and checking blood pressure, lipids and glucose on schedule allow problems to be fixed before symptoms appear.
Mood and sleep
The SWAN study (Bromberger 2011)
found women were 2–4 times more likely to have a major depressive episode during perimenopause and early postmenopause than before,
with a past history of depression the strongest risk factor. If low mood or exhaustion lasts more than 2 weeks, see a mental health professional.
Contraception
Pregnancy is still possible even when periods are irregular, so ask your doctor when it is safe to stop contraception.
5. Comparison table: lifestyle, therapy, hormones and nonhormone medicines
Options compared by drug class or generic name only. On mobile it shows as cards.
| Option | Best for | Evidence | Cautions |
|---|---|---|---|
| Exercise, weight control, regular sleep schedule | Everyone | Good for bone, heart and mood; does not clearly reduce hot flashes | Start gradually with heart or joint conditions |
| CBT and clinical hypnosis | Bothersome hot flashes, insomnia | Recommended by NAMS 2023 | Takes several weeks with a trained provider |
| Systemic hormone therapy (estradiol plus a progestogen if you have a uterus) | Under 60 or within 10 years of menopause, no contraindications | NAMS 2022: most effective for hot flashes; prevents bone loss | Not for women with prior breast cancer, blood clots or stroke |
| Low-dose vaginal estrogen | Vaginal dryness, burning, painful sex | Recommended by NAMS 2022 for local symptoms | Prescription required |
| Nonhormone medicines (SSRIs/SNRIs such as paroxetine and venlafaxine, gabapentin, fezolinetant, oxybutynin) | Cannot or prefer not to use hormones | Recommended by NAMS 2023 | Side effects vary; some need liver function monitoring |
| Herbs, supplements and unregulated compounded hormones | Not recommended for hot flashes | NAMS 2023: insufficient evidence | Some affect the liver or interact with other medicines |
6. Shared beliefs: how accurate are they?
- “One FSH test tells you whether you are in menopause” — not true. A single FSH result cannot confirm menopause because it swings widely during this stage.
- “A quiz will tell me what disease I have” — a questionnaire is not a diagnosis; it ranks symptoms and prepares you to talk to your doctor.
- “Thailand’s Universal Coverage gives every woman a mammogram at 40” — current coverage is for women aged 40 and over with a first-degree relative with breast cancer.
- “Catch it early and everyone recovers” — early detection greatly improves outcomes, but it does not promise the same result for everyone.
- “Hormone therapy gives everyone cancer, never use it” — risk depends on age, duration and hormone type; for suitable women, benefits outweigh risks.
Frequently Asked Questions (FAQ)
How can women aged 40–55 spot the first signs of perimenopause?
Under the STRAW+10 criteria, the first sign is a persistent difference of 7 days or more in the length of consecutive cycles. Later, gaps of 60 days or more without a period appear. Common symptoms include hot flashes, night sweats, poor sleep, mood swings and vaginal dryness. The SWAN study found frequent hot flashes lasted a median of 7.4 years, so it helps to log symptoms and cycles to discuss with your doctor.
What does a menopause symptom questionnaire do, and does it really reduce disease or costs?
Questionnaires such as the Menopause Rating Scale have 11 items scored 0–4. They measure severity, track change over time and make conversations with your doctor more focused. But a questionnaire is not a diagnosis, and no study shows that filling one in by itself reduces disease or treatment costs. The benefit comes when it leads to evidence-based screening such as mammograms and control of blood pressure, lipids and glucose.
When should FSH, LH and mammogram testing start, and what does Thai coverage include?
Per NICE guidance, women aged 45 and over with clear symptoms do not need an FSH test. A doctor may check FSH at ages 40–45 with symptoms and cycle changes, or under 40 when premature ovarian insufficiency is suspected. LH is not used to confirm perimenopause. Mammograms: the USPSTF recommends every 2 years from 40 to 74; the European guidelines give their strongest recommendation at 50–69 every 2 years. In Thailand, the NHSO covers mammogram plus ultrasound once every 2 years for women of every scheme aged 40 and over with a first-degree relative with breast cancer.
Which symptoms need a gynecologist promptly, without waiting?
Any vaginal bleeding after 12 months without a period (a meta-analysis found endometrial cancer in about 9% of this group), periods so heavy you change pads every 1–2 hours or pass large clots, bleeding between periods or after sex, a lump in the breast or armpit, and periods stopping before age 40. If you feel severely low or have thoughts of self-harm, contact a mental health crisis line. Chest pain with sweating or breathlessness needs emergency services.
Is hormone therapy dangerous, and who can use it?
The 2022 North American Menopause Society position statement concludes that for women under 60 or within 10 years of menopause and without contraindications, benefits outweigh risks for bothersome hot flashes and prevention of bone loss. Key contraindications include prior breast cancer, blood clots, stroke, or unexplained vaginal bleeding. Women with a uterus need a progestogen as well, and therapy must be prescribed by a doctor.
Without hormones, what has evidence for hot flashes?
The 2023 statement recommends cognitive behavioral therapy (CBT), clinical hypnosis, and prescribed nonhormone medicines such as SSRIs/SNRIs (paroxetine, venlafaxine), gabapentin, fezolinetant and oxybutynin. Herbal remedies and supplements are not recommended for hot flashes because the evidence is insufficient. Exercise does not clearly reduce hot flashes, but it remains essential for bone, heart and mood.
When does bone loss start, and when should bone density be checked?
SWAN found bone loss begins about 1 year before the final menstrual period and is fastest until 2 years after it. The lumbar spine lost 7.38% in this window, out of 10.6% over 10 years. The USPSTF 2025 recommends bone density screening for women 65 and over and for postmenopausal women under 65 at increased fracture risk. Meanwhile, do weight-bearing and strength exercise, get enough calcium from food, avoid smoking and limit alcohol.
Can FSH be tested while on birth control pills, and is contraception still needed?
Combined hormonal contraception and high-dose progestogens make FSH results uninterpretable, so NICE does not use FSH for diagnosis in this group, and FSH swings widely during perimenopause. A single FSH result cannot confirm menopause. Pregnancy is still possible even with irregular periods, so ask your doctor when it is safe to stop contraception.
Scientific mechanism in brief
Summarized by Asst. Prof. Dr. Norawit Raatpiboon:
the ovaries hold a limited number of follicles. As follicles run low, the inhibin B and AMH they produce fall, so the pituitary releases more FSH to push the ovaries.
The result is sharp estrogen swings and irregular ovulation, so progesterone, which is made after ovulation, falls first.
Lower estrogen narrows the temperature range the brain’s thermoregulatory center tolerates, which triggers hot flashes.
In bone, estrogen restrains bone-resorbing cells; as it falls, breakdown outpaces formation, especially from 1 year before to 2 years after the final period.
In blood vessels, shifts in blood lipids and abdominal fat raise long-term atherosclerosis risk.
Academic references (E-E-A-T)
- Harlow SD, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause 2012.
- Heinemann K, et al. The Menopause Rating Scale (MRS) scale: a methodological review. Health Qual Life Outcomes 2004.
- Avis NE, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 2015.
- Bromberger JT, et al. Major depression during and after the menopausal transition: Study of Women’s Health Across the Nation (SWAN). Psychol Med 2011.
- El Khoudary SR, et al. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. Circulation 2020.
- Greendale GA, et al. Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from SWAN. J Bone Miner Res 2012.
- US Preventive Services Task Force. Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2024.
- Schünemann HJ, et al. Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines. Ann Intern Med 2020.
- Lauby-Secretan B, et al. Breast-cancer screening: viewpoint of the IARC Working Group. N Engl J Med 2015.
- Clarke MA, et al. Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis. JAMA Intern Med 2018.
- US Preventive Services Task Force. Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement. JAMA 2025.
- The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 2022.
- The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause 2023.
- National Institute for Health and Care Excellence. Menopause: identification and management (NG23).
- National Health Security Office (NHSO), Thailand. Breast cancer benefits under the Universal Coverage Scheme (in Thai).
Compiled and reviewed by Asst. Prof. Dr. Norawit Raatpiboon · Drug classes and generic names only; no brand names.
Medical disclaimer
This article provides general information from research and clinical guidelines. It is not a diagnosis, not a prescription, and cannot replace a visit to a doctor or gynecologist. Symptom questionnaires only help rank urgency. Coverage may change with official announcements; check with your health unit or the NHSO hotline 1330. Do not buy hormones, herbs or supplements to use on your own. If you have any of the red flags above, see a doctor, or call emergency services (Thailand: 1669).